🔴 NeOnc Technologies Holdings is trading 10% down today with no clear company-specific catalyst identified

NeOnc Technologies Holdings is trading 10.24% down now at $2.94, with no clear company-specific catalyst identified.

• The October 26 announcement described a proposed trial targeting approximately 500 patients across 30 hospitals in three countries; it did not report completed enrollment or results.
• Available reporting does not link the announcement to the selloff. Major U.S. indexes were higher, so broader market weakness does not explain the move.